Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. (GBT) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
gbt · market cap & enterprise value · FMP · as of Oct 4, 2022
Core market cap & key metrics
As of Oct 4, 2022, Global Blood Therapeutics, Inc. (GBT) has a market cap — also referred to as its net worth or valuation — of $0, making it one of the top most valuable companies globally. Market Cap = $68.49 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Global Blood Therapeutics, Inc. (GBT) has a market cap — also referred to as its net worth or valuation — of $0 as of Oct 4, 2022, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Global Blood Therapeutics, Inc. reached its all-time high market cap of $4.6B on Dec 31, 2019. Comparing the Global Blood Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Global Blood Therapeutics, Inc. net worth vs peers and ask how Global Blood Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
GBT market cap · 6 questionsGlobal Blood Therapeutics, Inc.'s net worth — measured as market capitalization — is $0 as of Oct 4, 2022. It ranks #0 globally. Market Cap = $$68.49 (price) × shares outstanding.